Connect with us


Akwa Ibom approves N3bn for ‘critical projects’ in AKSU


The Akwa Ibom Government has approved N3 billion to develop critical infrastructure in Akwa Ibom State University (AKSU), Ini Ememobong, the institution’s information and strategy commissioner, disclosed this on Wednesday in Uyo.

Ememobong, in a statement, said that Gov. Udom Emmanuel gave the approval at the State Executive Council meeting.

According to him, the money is meant to provide critical development in line with the master plan of the university.

He said that the governor sought for an improved version of the scholarship proposed for undergraduate and post- graduate students, adding that it was designed with special packages to accommodate some professional courses.

“Council was notified of award of projects to the tune of N3billion to the Akwa Ibom State University, through the intervention of the Governor.

“The projects will provide critical infrastructure in the university in line with the strategic development plan of the state government for the institution” she said.

He said that the special scholarship scheme signposted the need for strategic scholarship awards in the areas of aviation, maritime, science and technology, in view of the opportunities the areas offer and their comparative advantages,” he said.

MORE READING!  Super Tucano fighter planes brought to end violent extremism in Nigeria - US envoy

The commissioner quoted the governor as advising the executive council members to be diligent in the discharge of their duties to boost efficiency, yield better results and check unnecessary errors.

He revealed that many mega investment activities would soon flood the state and directed members to liaise with youths and community leaders in their jurisdictions so that they would cooperate with the investors when they arrived.

MORE READING!  Prison decongestion: 12 inmates freed by Ebonyi judge

Ememobong said that the governor had directed the Ministry of Health to track the global performance status of COVID-19 vaccines curently being administered and its adverse reaction rate.